| Similar Articles |
|---|
 |
Chemistry World
September 23, 2014
Andy Extance |
Bayer to sever polymer arm The German chemical giant has announced plans to spin off its MaterialScience business as a new company within 12 -- 18 months.   |
Chemistry World
October 31, 2012
Andrew Turley |
Bayer spends $1.2bn on supplement maker German healthcare giant Bayer has struck a deal to buy Schiff Nutrition, a US company specializing in vitamins and nutritional supplements, for $1.2 billion. |
The Motley Fool
September 5, 2006
Brian Gorman |
Bayer Rising? Bayer still has some hoops to jump through before it's in tip-top shape, but the company has some tantalizing opportunities. Investors, it's not too early to put the German conglomerate on the watch list. |
Chemistry World
November 23, 2012
Andrew Turley |
Schiff seals deal with Reckitt The billion-dollar tussle between German healthcare giant Bayer and UK consumer products firm Reckitt Benckiser over Schiff Nutrition has been resolved with Reckitt winning out. |
Chemistry World
November 16, 2012
Andrew Turley |
What lies within Bayer is looking to 'modestly' increase its R&D budget next year -- it was 3 billion euros( 2.4 billion pounds) for 2012 -- and place new emphasis on transferring ideas between research areas within the company. |
The Motley Fool
November 29, 2004
Brian Gorman |
Glass Half Full for Bayer Bayer is battling drug recall demons, but the company's positives seem to outweigh its negatives. The German drug and chemical giant posted a net profit of $42 million, reversing a massive loss recorded in the same period last year. |
IndustryWeek
September 1, 2002
John S. McClenahen |
Bayer's Formula: Two Sites Both Research Triangle Park, N.C., and Kansas City, Mo., are home to newly created Bayer CropScience's North American Operations. |
Chemistry World
March 7, 2014
Emma Stoye |
Bayer agrees seed firm takeover in Argentina Agrochemicals giant Bayer CropScience has signed an agreement to acquire Biagro Group, a biological seed treatment producer with headquarters in Argentina. |
The Motley Fool
August 7, 2007
Brian Lawler |
Nektar Makes a Deal Nektar Therapeutics signs a deal with Bayer AG in an effort to move itself closer to profitability. In return, Bayer gets a co-promotion profit-sharing deal in the U.S., and commercialization rights elsewhere. |
Fast Company
November 2003
Loch Adamson |
Wanted: A Few Good Microbes Problem: How to reduce usage of chemical pesticides. Solution: Develop natural products based on killer bacteria. |
The Motley Fool
November 30, 2006
Brian Lawler |
Not Bad, Bayer The company's buyout of fellow German firm Schering AG looks like a boon to its bottom line. Investors, take note. |
Chemistry World
September 25, 2015
Rebecca Trager |
Bayer CropScience pays $5.6m to settle 2008 accident charges Under the agreement, the company will enhance safeguards at its US chemical facilities. |
The Motley Fool
March 27, 2006
Rich Smith |
Bayer Prescribes Itself a Buyout Bayer's bid for Schering trumped an earlier $17.5 billion offer from yet another German powerhouse, Merck KGaA. Why would Bayer pay so much for Schering? Investors, take note. |
Chemistry World
September 2, 2009
Helen Carmichael |
Bayer bows to safety concerns One year after an explosion that led to two fatalities, Bayer CropScience is to eliminate 80 per cent of its methyl isocyanate stockpile at its Institute, West Virginia site. |
Chemistry World
April 29, 2013 |
Bayer buys Conceptus for $1.1bn The deal gives Bayer access to Essure, a non-surgical procedure for permanent birth control. |
The Motley Fool
March 3, 2005
Brian Gorman |
Bayer Heals Itself The latest earnings report suggests things are looking up -- and drug development may soon yield more good news for investors. |
Chemistry World
October 5, 2012
Phhillip Broadwith |
Bayer and Evotec team up on endometriosis Bayer Healthcare and Evotec have agreed to collaborate in their search for drugs for endometriosis, a disease in which cells of the type that normally line the uterus wall grow outside of the womb. |
Pharmaceutical Executive
November 1, 2006
Patrick Clinton |
Man in a Hurry Bureaucratic? Bayer? Not if you ask Arthur Higgins. In just over two years, the head of Bayer HealthCare has proved that pharma can be a quick and nimble business. |
The Motley Fool
August 29, 2006
S.J. Caplan |
Bayer's Crop Headache The company's second-quarter earnings are up while crops drag. Investors, take note. |
The Motley Fool
April 2, 2004
Brian Gorman |
Bayer's Food Fight Bayer's recent U.K. troubles reflect Europe's continued distaste for genetically modified foods. |
The Motley Fool
October 16, 2006
Brian Lawler |
Bayer's Big Drug Boo-Boo The company's forgetfulness could end up hurting its reputation even worse than its revenues. |
Chemistry World
September 18, 2012
Andrew Turley |
Bayer $145 million animal health deal Bayer has signed a $145 million deal to buy the US part of the animal health business at Israeli generics giant Teva. |
The Motley Fool
July 20, 2004
Brian Gorman |
Bayer Reshuffles Business Bayer, one of Germany's most venerable industrial names, is revamping its house. Seemingly in one fell swoop, the company is spinning off its Lanxess chemicals and polymers unit and buying Roche's over-the-counter-drugs business. |
Chemistry World
June 22, 2007
Ned Stafford |
Big Pharma Not Interested in 'Male Pill' German drug giant Bayer has officially stopped research and development of a hormonal male contraceptive, yet another sign that the pharma industry has lost interest in developing the so-called 'male pill.' |
BusinessWeek
October 13, 2003
Gene G. Marcial |
Sontra Medical Looks Healthier with Bayer With giant Bayer as a partner, tiny Sontra Medical could make it big in the $5 billion market for home glucose testing for diabetics. |
IndustryWeek
January 19, 2011 |
Bayer's Prescription: More Innovation, Less Administration Bayer stokes product pipeline and sees accelerated growth in emerging markets. |
Chemistry World
May 9, 2014
Andy Extance |
Bayer wins race to buy Merck & Co consumer care Germany's Bayer has won a bidding contest for US giant Merck & Co's consumer care business unit, seemingly thanks to a heart drug collaboration sweetener. |
Chemistry World
January 18, 2013
Ned Stafford |
EU food agency links pesticides to bee decline Chemical giants Bayer CropScience and Syngenta are both disputing the conclusions of a report from the European Food Safety Authority that says that bees might be at risk from neonicotinoid insecticides produced by the two companies. |
The Motley Fool
June 25, 2008
Brian Orelli |
An Even More Complicated Patent Settlement Barr and Bayer settle their dispute about Yasmin. That's as simple as it gets. |
Chemistry World
May 9, 2013
Phillip Broadwith |
Carbon nanotubes not commercially viable for Bayer Large-scale commercialization of carbon nanotubes is off the radar at Bayer MaterialScience. The company is shutting down its Baytubes pilot plant. |
The Motley Fool
February 22, 2006
Rich Smith |
1001 Teutonic Nights, Part 2 Investors, get to know Germany: BASF... Bayer... SGL Carbon... Pfeiffer Vacuum... |
